September 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit ~2 min.ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....
September 3, 2025ASTRAZENECA PLC Hits 11.81% Profit Target as Forecasted by QuantWave ~1 min.ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....
September 3, 2025ASTRAZENECA PLC Stock Hits QuantWave Price Target with Profit of 19.38% ~1 min.On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....
September 3, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 17.98% Profit ~1 min.On July 16, 2025, QuantWave's automated forecasting platform issued a signal for ASTRAZENECA PLC, predicting a long position with the stock trading at $69.6....
September 3, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.12% Profit ~2 min.On July 31, 2025, QuantWave, an automated forecasting platform, issued a long signal for ASTRAZENECA PLC when the stock was trading at $72.59....
September 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast Target with 11.64% Profit ~2 min.ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.64%. The forecast signal was issued on August 8, 2025, with the stock priced at $73....
September 3, 2025ASTRAZENECA PLC Stock Hits Price Target with 12.34% Profit: QuantWave Forecast Success ~1 min.ASTRAZENECA PLC stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 12.34%. The forecast signal was generated on August 6, 2025, with a price of $73....
September 3, 2025QuantWave Successfully Hits Price Target Forecast for AstraZeneca PLC, Yielding 15.25% Profit ~2 min.On July 14, 2025, QuantWave, the automated forecasting platform, issued a signal to go long on AstraZeneca PLC with a price of $71.24....
August 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer ~1 min.AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....
August 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit ~1 min.On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....
November 2, 2024AstraZeneca Faces Investigation Over China President's Conduct ~1 min.AstraZeneca PLC (NASDAQ:AZN) has come under scrutiny as its China President, Leon Wang, is being investigated for misconduct. The company's shares rose slightly but lagged behind the market. Investors are advised to stay informed about the investigation's progress and seek professional advice from Stocks Prognosis for accurate stock forecasts.
December 13, 2024Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000....
November 4, 2024Investors Should Know: AstraZeneca AZN Rises, But Trails Market ~1 min.Recently, pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) has seen its stock price rise, but not at the same pace as the overall market....
December 14, 2024Hagens Berman Alleges Fraud and Corruption in AstraZeneca AZN; Shares Plummet ~1 min.Leading law firm Hagens Berman has initiated an investigation into British pharmaceutical giant AstraZeneca PLC (NASDAQ:AZN) following reports of potential fraud and corruption within the company....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
